Moreover, TGF-β was shown to upregulate L1CAM to trigger binding of integrins, resulting in induction of IL-1β secretion and EMT promotion in pancreatic and breast cancers [53, 54]. This evidence concerns the gene TGFB1 and breast carcinoma.